"Comment Number",Ballot,Chapter,Section,Page #,Line #,Artifact ID,Resource(s),HTML Page name(s),URL,Vote and Type,Sub-category,Tracker #,Existing Wording,Proposed Wording,Ballot Comment,Summary,In person resolution requested,Comment grouping,Schedule,Triage Note,Pubs,Disposition WG,Disposition,Disposition Comment or Retract/Withdraw details,Disposition/Retract/ Withdrawal Date,Mover / seconder,For ,Against,Abstain,Retracted / Withdrawn,Disposition External Organization,Responsible Person,Change Applied,Substantive Change,Submitted By,Organization,On behalf of,Commenter Email,Submitter Tracking ID,Referred To,Received From,Notes,,
1,US Pharmacy,,Introduction,,,,ImplementationGuide,,http://hl7.org/fhir/us/meds/2018May/pdmp.html,A-C,,,respect to prescribing and use of controlled substances,respect to prescribing and use of controlled substances (primarily opioids),,Update reference to Opioids,,Ready-for-Vote,,,,,Persuasive with mod,will update to (e.g. Opioids),,,,,,,,,,,Michele Hudak ,Defense Health Agency/Military Health System ,,,,,,,,
2,US Pharmacy,,Introduction,,,,ImplementationGuide,,http://hl7.org/fhir/us/meds/2018May/pdmp.html,A-C,,,abuse and diversion also commonly known as Opioid abuse,abuse and diversion.,"Controlled substances are a broad classification of medications that are considered ""habit forming"" by the DEA. Controlled substances include stimulants, benzodiazepines and opioids (to name a few). Recommend leaving off the term ""opioid abuse"" since it doesn not accurately reflect the spectrum of substance use disorders than can be caused by habit forming substances",Remove specific call-out of Opioid abuse,,Ready-for-Vote,,,,,Persuasive,Will update.,,,,,,,,,,,Michele Hudak ,Defense Health Agency/Military Health System ,,,,,,,,
3,US Pharmacy,,Introduction,,,,ImplementationGuide,,http://hl7.org/fhir/us/meds/2018May/pdmp.html,A-C,,,history before prescribing any controlled substances,history before prescribing certain controlled substances,,Drop phrase 'any' on controlled substance,,Ready-for-Vote,,,,,Persuasive,Will update to 'history before prescribing controlled substances',,,,,,,,,,,Michele Hudak ,Defense Health Agency/Military Health System ,,,,,,,,
4,US Pharmacy,,NCPDP Mappings for PDMP Response,,,,ImplementationGuide,,http://hl7.org/fhir/us/meds/2018May/pdmp.html,A-Q,,,,,Patient Identifier--only option is SSN. Not sure if this is always collected by pharmacies,Confirm if SSN is only identifier,,Ready-for-Vote,,,,,Considered - Question Answered,SSN is the data element provided by the PDMP response and you are correct it may not always be present. Other identifiers would be allowed in the FHIR Patient.identifier. ,,,,,,,,,,,Michele Hudak ,Defense Health Agency/Military Health System ,,,,,,,,
5,US Pharmacy,,,,,,ImplementationGuide,,http://hl7.org/fhir/us/meds/2018May/index.html,A-S,Enhancement,,"This guide applies the general Argonaut Project scope statement and adopts it specifically to enable a user to access, record, change a patientâs active medications as well as a medication history. This covers the Meaningful Use 2015 Â§?170.302(d) certification requirement for EHRs.",,"This passage makes a reference to the Argonaut Project statement but then requires the user to dig around for the scope statement as it's not specifically labelled within the hyperlink.  While the Argonaut Project description is definitely informative, and should stay, providing the scope up front is far more convenient.",Make the scope statement include the Argonaut Project scope statement for convenience.,,Ready-for-Vote,,,,,Persuasive with mod,Will update to 'Argonaut Project use cases',,,,,,,,,,,Kanwarpreet Sethi ,Lantana Consulting Group  ,Arvind Jagannathan ,arvind.jagannathan@lantanagroup.com ,,,,,,
6,US Pharmacy,,,,,,ImplementationGuide,,http://hl7.org/fhir/us/meds/2018May/guidance.html,A-S,Correction,,A patient or related person may directly report the information or provide some type of record including other FHIR resources. The information from an ordering system may also be used to create a MedicationRequest resource.,A patient or related person may directly report the information or provide some type of record including other FHIR resources. The information from an ordering system may also be used to create a MedicationStatement resource.,Did you actually mean MedicationStatement here when you wrote MedicationRequest? It seems out of place to suddenly mention MedicationRequest when MedicationStatement is the focus of the section.,Did you actually mean MedicationStatement here when you wrote MedicationRequest?,,Ready-for-Vote,,,,,Persuasive,Will update.,,,,,,,,,,,Kanwarpreet Sethi ,Lantana Consulting Group  ,Arvind Jagannathan ,arvind.jagannathan@lantanagroup.com ,,,,,,
7,US Pharmacy,,,,,,ImplementationGuide,,http://hl7.org/fhir/us/meds/2018May/pdmp.html,A-S,Clarification,,"PDMP Responders which are acting as intermediaries provide additional value add services such being able to query multiple State PDMP systems, analytics which provide additional information for the Provider requesting the information.","PDMP Responders, which act as intermediaries, provide additional services such as being able to query multiple State PDMP systems for analytics which generates additional information for the Provider.",The wording needs to be clarified for this sentence.  The english seems a bit off and I'm not 100% sure what is being referred to.  I took a stab at rewording it but if some of the intended informaiton isn't conveyed please feel free to disregard my rewording.,Reword this sentence within the PDMP section.,,Ready-for-Vote,,,,,Persuasive,Will update.,,,,,,,,,,,Kanwarpreet Sethi ,Lantana Consulting Group  ,Arvind Jagannathan ,arvind.jagannathan@lantanagroup.com ,,,,,,
8,US Pharmacy,,,,,,ImplementationGuide,,http://hl7.org/fhir/us/meds/2018May/pdmp.html,A-T,Enhancement,,This section describes identifies data elements that are used commonly in the PDMP data requests and responses and provides mappings of these data elements to FHIR.,This section describes and identifies data elements that are used commonly in the PDMP data requests and responses and also provides mappings of these data elements to FHIR.,Just a minor typo correction by adding a word or two.,Just a typo correction within the PDMP section.,,Ready-for-Vote,,,,,Persuasive,Will update.,,,,,,,,,,,Kanwarpreet Sethi ,Lantana Consulting Group  ,Arvind Jagannathan ,arvind.jagannathan@lantanagroup.com ,,,,,,
9,US Pharmacy,,,,,,ImplementationGuide,,http://hl7.org/fhir/us/meds/2018May/pdmp.html,A-S,Enhancement,,This section describes identifies data elements that are used commonly in the PDMP data requests and responses and provides mappings of these data elements to FHIR.,,Is this supposed to be the start of a new major section? If so the header's formatting needs to be changed to show it.,Change the format of the header for the PDMP Data Elements and Mappings section to properly show this is a new major section of this page.,,Ready-for-Vote,,,,,Persuasive,Will update.,,,,,,,,,,,Kanwarpreet Sethi ,Lantana Consulting Group  ,Arvind Jagannathan ,arvind.jagannathan@lantanagroup.com ,,,,,,
10,US Pharmacy,,,,,,ImplementationGuide,,http://hl7.org/fhir/us/meds/2018May/CapabilityStatement-server.html,A-S,Enhancement,,Implement the RESTful behavior according to the FHIR specification.,,Would probably be good to provide a link to the FHIR RESTful specification for convenience here (https://www.hl7.org/fhir/http.html).,Provide a link to the FHIR RESTful specification within the CapabilityStatement description.,,Ready-for-Vote,,,,,Persuasive,Will update.,,,,,,,,,,,Kanwarpreet Sethi ,Lantana Consulting Group  ,Arvind Jagannathan ,arvind.jagannathan@lantanagroup.com ,,,,,,
11,,,,,,,,,,NEG,,16032,,,,,,,,16032 - wrong ballot.,,,,,,,,,,,,,,,Ruth Berge ,GE Healthcare Digital ,,,,,,,,
12,,,,,,,,,,NEG,,16091,,,,,,,,,,,,,,,,,,,,,,,Ruth Berge ,GE Healthcare Digital ,,,,,,,,
13,,,,,,,,,,NEG,,16090,,,,,,,,,,,,,,,,,,,,,,,Ruth Berge ,GE Healthcare Digital ,,,,,,,,
14,,,,,,,,,,A-S,,16094,,,,,,,,,,,,,,,,,,,,,,,Ruth Berge ,GE Healthcare Digital ,,,,,,,,
15,,,,,,,,,,A-Q,,16093,,,,,,,,16093 - wrong ballot.,,,,,,,,,,,,,,,Ruth Berge ,GE Healthcare Digital ,,,,,,,,
16,,,,,,,,,,A-S,,16326,,,,,,,,,,,,,,,,,,,,,,,Scott Robertson ,Kaiser Permanente ,,,,,,,,
17,,,,,,,,,,A-C,,16327,,,,,,,,,,,,,,,,,,,,,,,Scott Robertson ,Kaiser Permanente ,,,,,,,,
18,US Pharmacy,,SBADM,,,,ImplementationGuide,,,A-Q,,,"EVN will be used to record a medication statement where the patient is currently taking or has taken the medication in the past. INT will be used to record a medication statement where the patient plans to take the medication or be
administered the medication in the future.",,"Both options can be simultaeously true. A substance can be taken in the past, not currently be consumed, but restarted in the future.","Both options can be simultaeously true. A substance can be taken in the past, not currently be consumed, but restarted in the future.",,,,,,,,,,,,,,,,,,,Steve Eichner ,,,,,,,,,
19,US Pharmacy,,,,,,ImplementationGuide,,,A-Q,,,,,Is there a location  for text entry? There are medicines that do not have an existing code because they are a custom compounded substance or are in trial.,Is there a location  for text entry? There are medicines that do not have an existing code because they are a custom compounded substance or are in trial.,,,,,,,,,,,,,,,,,,,Steve Eichner ,,,,,,,,,
20,US Pharmacy,,NCPDP Mapping Tables,,,,ImplementationGuide,,http://hl7.org/fhir/us/meds/2018May/pdmp.html,A-Q,,,"""terisk""","""asterisk""",Why not spell it out?,"""asterisk"" misspelt",,,,,,,,,,,,,,,,,,,Thomson Kuhn,ACP,,,,,,,,,
21,US Pharmacy,,NCPDP Mappings for PDMP Responses,,,,ImplementationGuide,,http://hl7.org/fhir/us/meds/2018May/pdmp.html,A-Q,,,Patient Identifier | SSN*,,This data element has an asterisk however there are no choices available and indicated in this case.  What is the meaning of the asterisk for this element?,What is the meaning of the asterisk for this element.,,,,,,,,,,,,,,,,,,,Thomson Kuhn,ACP,,,,,,,,,
22,US Pharmacy,,,,,,ImplementationGuide,,,A-Q,,,,,"The required elements for identification of this patient profile search are name, birthdate and the required period of the search. In a highly populated state this may result in several hits or incorrect hits.",Patient Profile Search Requirements,,,,,,,,,,,,,,,,,,,Mark Cacciapouti ,Wolters Kluwer Health  ,,,,,,,,
23,US Pharmacy,,,,,,ImplementationGuide,,,A-C,,,,,"Agree with approach. Some parts can be valid internationally, but only after careful re-analysis of US-centric content (e.g. PDMP, NCPDP) and intended use context.",Agree with approach,,,,,,,,,,,,,,,,,,,Jose Costa Teixeira ,HL7 Germany ,,,,,,,,
24,US Pharmacy,,,,,,ImplementationGuide,,,NEG,Correction,,,,"The specification as ingredient and package, but not the regulated medicinal product and not the pharmaceutical product. It seems not to adhere to the Identification of Medicinal Products IDMP from ISO.",Seems not to adhere to the Identification of Medicinal Products IDMP from ISO.,,,,,,,,,,,,,,,,,,,William Goosen,HL7 Netherlands ,,,,,,,,
